The dynamic situation surrounding the new corona virus also requires drastic measures from us at Roland Berger. We see it as our duty to prevent further spread of the virus and thus contribute to the general safety and health of all people around us. For this reason, our Spring / Summer events will be postponed or cancelled for the time being. Despite the challenging situation, we are here for you with our expertise and believe that together we can find a quick return to normality.

As the "New Normal" is on the doorsteps, our Partners Casper Veenman and Jan-Philipp Hasenberg reflect on what the new situation means for the Automotive industry and how to adjust long-term strategic alignments.

Morris Hosseini is a Partner in the Pharma & Healthcare Competence Center in Berlin.

He advises global clients on commercial strategies, including go-to-market models, medical affairs and market access topics. His consulting practice also focuses on digital transformation, including multi-channel approaches, and performance topics such as operational excellence, research and development and organizational effectiveness, including change management. Prior to joining Roland Berger, Morris Hosseini worked as a researcher in regenerative medicine and co-founded a biotech company on stem cell applications in Canada. He holds a Ph.D. in Biomedical Engineering from the University of Toronto in Canada.

"Medicine is increasingly becoming predictive, preventive, personalized and participatory. This will create challenges and opportunities to leverage novel therapeutic strategies."